Geneart Doubles Tradable Shares with Bonus Stock Issue | GenomeWeb
NEW YORK (GenomeWeb News) – Gene synthesis firm Geneart said Friday that it planned to issue bonus shares in a 1:1 ratio in order to double its number of tradable shares. 
Geneart, based in Regensburg, Germany, is listed on the German Stock Exchange.
The company said that the issue of bonus shares is comparable to a 1:1 stock split. It doubles the number of shares for each account, while the price of each share is halved.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.